Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Oger

Showing results (101-110 of 181) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|June 3, 2020
Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitalsMarie-Noëlle Osmont, Adeline Degremont, Hélène Jantzem, et al.
Neuroepidemiology|February 27, 2025
Excess Mortality in Adults and Adolescents with Epilepsy, View from a 10-Year Nationwide CohortChris Serrand, Frederic Balusson, Adeline Degremont, et al.
Journal of Inherited Metabolic Disease|June 7, 2012
Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardationRaphaël Teissier, Emmanuel Nowak, Murielle Assoun, et al.
European Heart Journal. Cardiovascular Imaging|January 18, 2024
Transcatheter aortic valve implantation in severe aortic stenosis does not necessarily reverse left ventricular myocardial damage: data of long-term follow-upFrederic Myon, Benjamin Marut, Wojciech Kosmala, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Impact of rotavirus vaccine on premature infantsJean-Michel Roué, Emmanuel Nowak, Grégoire Le Gal, et al.
Archives of Cardiovascular Diseases|October 27, 2015
Electrocardiographic correlates of mechanical dyssynchrony in recipients of cardiac resynchronization therapy devicesAlbin Behaghel, Anne Brunet-Bernard, Emmanuel Oger, et al.
Thrombosis Research|June 15, 2007
Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolismGrégoire Le Gal, Bénédicte Delahousse, Karine Lacut, et al.
ESC Heart Failure|August 10, 2021
Predictors of long-term outcome in heart failure with preserved ejection fraction: a follow-up from the KaRen studyAngiza Shahim, Marion Hourqueig, Erwan Donal, et al.
Blood Pressure|December 23, 2014
Is home blood pressure monitoring feasible and well accepted in nephrectomized patients for renal cancer? (STAFF study)Nolwenn Lorcy, Caroline Dourmap-Collas, Alexandre Lafourcade, et al.
ESC Heart Failure|November 23, 2021
Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trialLars H Lund, Gianluigi Savarese, Ashwin Venkateshvaran, et al.
Pageof 19

Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|June 3, 2020
Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitalsMarie-Noëlle Osmont, Adeline Degremont, Hélène Jantzem, et al.
Neuroepidemiology|February 27, 2025
Excess Mortality in Adults and Adolescents with Epilepsy, View from a 10-Year Nationwide CohortChris Serrand, Frederic Balusson, Adeline Degremont, et al.
Journal of Inherited Metabolic Disease|June 7, 2012
Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardationRaphaël Teissier, Emmanuel Nowak, Murielle Assoun, et al.
European Heart Journal. Cardiovascular Imaging|January 18, 2024
Transcatheter aortic valve implantation in severe aortic stenosis does not necessarily reverse left ventricular myocardial damage: data of long-term follow-upFrederic Myon, Benjamin Marut, Wojciech Kosmala, et al.
Clinical and Vaccine Immunology : CVI|August 1, 2014
Impact of rotavirus vaccine on premature infantsJean-Michel Roué, Emmanuel Nowak, Grégoire Le Gal, et al.
Archives of Cardiovascular Diseases|October 27, 2015
Electrocardiographic correlates of mechanical dyssynchrony in recipients of cardiac resynchronization therapy devicesAlbin Behaghel, Anne Brunet-Bernard, Emmanuel Oger, et al.
Thrombosis Research|June 15, 2007
Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolismGrégoire Le Gal, Bénédicte Delahousse, Karine Lacut, et al.
ESC Heart Failure|August 10, 2021
Predictors of long-term outcome in heart failure with preserved ejection fraction: a follow-up from the KaRen studyAngiza Shahim, Marion Hourqueig, Erwan Donal, et al.
Blood Pressure|December 23, 2014
Is home blood pressure monitoring feasible and well accepted in nephrectomized patients for renal cancer? (STAFF study)Nolwenn Lorcy, Caroline Dourmap-Collas, Alexandre Lafourcade, et al.
ESC Heart Failure|November 23, 2021
Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trialLars H Lund, Gianluigi Savarese, Ashwin Venkateshvaran, et al.
Pageof 19